These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16056007)

  • 1. Incorporating information about cost-effectiveness into evidence-based decision-making: the evidence-based practice center (EPC) model.
    Helfand M
    Med Care; 2005 Jul; 43(7 Suppl):33-43. PubMed ID: 16056007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic reviews of economic evaluations: utility or futility?
    Anderson R
    Health Econ; 2010 Mar; 19(3):350-64. PubMed ID: 19378354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using economic evidence in clinical practice.
    Stone PW
    J Med Pract Manage; 2002; 17(5):272-7. PubMed ID: 12024866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporating considerations of cost-effectiveness, affordability, and resource implications in guideline development: article 6 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Hill SR; Olson LG; Falck-Ytter Y; Cruz AA; Atkins D; Baumann M; Jaeschke R; Woitalla T; Schünemann HJ;
    Proc Am Thorac Soc; 2012 Dec; 9(5):251-5. PubMed ID: 23256167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conducting systematic reviews of economic evaluations.
    Gomersall JS; Jadotte YT; Xue Y; Lockwood S; Riddle D; Preda A
    Int J Evid Based Healthc; 2015 Sep; 13(3):170-8. PubMed ID: 26288063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Use of Economic Evidence to Inform Drug Pricing Decisions in Jordan.
    Hammad EA
    Value Health; 2016; 19(2):233-8. PubMed ID: 27021758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The art and science of incorporating cost effectiveness into evidence-based recommendations for clinical preventive services.
    Saha S; Hoerger TJ; Pignone MP; Teutsch SM; Helfand M; Mandelblatt JS;
    Am J Prev Med; 2001 Apr; 20(3 Suppl):36-43. PubMed ID: 11306230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder.
    Bereza BG; Machado M; Einarson TR
    Clin Ther; 2009 Jun; 31(6):1279-308. PubMed ID: 19695395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab, adalimumab and golimumab for treating moderately to severely active ulcerative colitis after the failure of conventional therapy (including a review of TA140 and TA262): clinical effectiveness systematic review and economic model.
    Archer R; Tappenden P; Ren S; Martyn-St James M; Harvey R; Basarir H; Stevens J; Carroll C; Cantrell A; Lobo A; Hoque S
    Health Technol Assess; 2016 May; 20(39):1-326. PubMed ID: 27220829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evidence in decision-making process in laboratory medicine.
    Brunetti M; Pregno S; Schünemann H; Plebani M; Trenti T
    Clin Chem Lab Med; 2011 Apr; 49(4):617-21. PubMed ID: 21391868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical effectiveness and cost-effectiveness of second-eye cataract surgery: a systematic review and economic evaluation.
    Frampton G; Harris P; Cooper K; Lotery A; Shepherd J
    Health Technol Assess; 2014 Nov; 18(68):1-205, v-vi. PubMed ID: 25405576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sepsis: the LightCycler SeptiFast Test MGRADE®, SepsiTest™ and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi - a systematic review and economic evaluation.
    Stevenson M; Pandor A; Martyn-St James M; Rafia R; Uttley L; Stevens J; Sanderson J; Wong R; Perkins GD; McMullan R; Dark P
    Health Technol Assess; 2016 Jun; 20(46):1-246. PubMed ID: 27355222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of evidence in economic decision models: practical issues and methodological challenges.
    Cooper NJ; Sutton AJ; Ades AE; Paisley S; Jones DR;
    Health Econ; 2007 Dec; 16(12):1277-86. PubMed ID: 18034447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the clinical effectiveness and cost-effectiveness of conservative interventions for tendinopathy? An overview of systematic reviews of clinical effectiveness and systematic review of economic evaluations.
    Long L; Briscoe S; Cooper C; Hyde C; Crathorne L
    Health Technol Assess; 2015 Jan; 19(8):1-134. PubMed ID: 25629427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis.
    Frampton GK; Jones J; Rose M; Payne L
    Health Technol Assess; 2016 Nov; 20(87):1-160. PubMed ID: 27918253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Most guideline organizations lack explicit guidance in how to incorporate cost considerations.
    Sanabria AJ; Kotzeva A; Selva Olid A; Pequeño S; Vernooij RWM; Martínez García L; Zhang Y; Solà I; Thornton J; Alonso-Coello P
    J Clin Epidemiol; 2019 Dec; 116():72-83. PubMed ID: 31430507
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.